Cardiovascular disease

J M Gore1, J E Dalen

  • 1University of Massachusetts Medical School, Worcester, USA.

JAMA
|June 7, 1995
PubMed

Insights

Thrombolytic therapy offers no benefit and may harm patients with unstable angina or non-Q-wave myocardial infarction. However, treating high cholesterol improves survival in coronary artery disease patients.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Pharmacology

Background:

  • Unstable angina and non-Q-wave myocardial infarction are critical cardiovascular conditions.
  • The efficacy and safety of thrombolytic therapy in these conditions require rigorous investigation.
  • Management of hypercholesterolemia is crucial for patients with established coronary artery disease.

Purpose of the Study:

  • To evaluate the effectiveness and safety of thrombolytic therapy in patients with unstable angina or non-Q-wave myocardial infarction.
  • To assess the impact of drug treatment for hypercholesterolemia on survival in patients with coronary artery disease.

Main Methods:

  • The Thrombolysis in Myocardial Ischemia trial randomized patients to receive either thrombolytic therapy or a control.
  • Survival rates were analyzed in patients receiving drug treatment for hypercholesterolemia versus those not receiving such treatment.

Main Results:

  • Thrombolytic therapy did not demonstrate benefit and was associated with potential harm in the studied patient population.
  • Drug treatment for hypercholesterolemia was shown to improve survival rates in patients with existing coronary artery disease.

Conclusions:

  • Thrombolytic therapy is not recommended for unstable angina or non-Q-wave myocardial infarction.
  • Aggressive lipid-lowering therapy is beneficial for improving survival in patients with coronary artery disease.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...